BFA
AERI

BlackRock Fund Advisors’s Aerie Pharmaceuticals AERI Stock Holding History

BlackRock Fund Advisors’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$61.8M Buy
1,631,500
+589,020
+57% +$22.3M 0.01% 1547
2016
Q3 		$39.3M Buy
1,042,480
+70,584
+7% +$1.56M 0.01% 1735
2016
Q2 		$17.1M Buy
971,896
+92,113
+10% +$1.49M ﹤0.01% 2112
2016
Q1 		$10.7M Buy
879,783
+17,704
+2% +$280K ﹤0.01% 2304
2015
Q4 		$21M Sell
862,079
-44,088
-5% -$1.03M ﹤0.01% 2013
2015
Q3 		$16.1M Buy
906,167
+36,518
+4% +$661K ﹤0.01% 2135
2015
Q2 		$15.3M Buy
869,649
+271,357
+45% +$4.97M ﹤0.01% 2273
2015
Q1 		$18.8M Buy
598,292
+24,620
+4% +$714K ﹤0.01% 2112
2014
Q4 		$16.7M Buy
573,672
+324,574
+130% +$8.23M ﹤0.01% 2167
2014
Q3 		$5.15M Sell
249,098
-6,223
-2% -$123K ﹤0.01% 2738
2014
Q2 		$6.32M Buy
255,321
+34,198
+15% +$592K ﹤0.01% 2698
2014
Q1 		$4.69M Buy
221,123
+15,030
+7% +$304K ﹤0.01% 2866
2013
Q4 		$3.7M Buy
+206,093
New +$2.68M ﹤0.01% 2983

Other funds holding AERI

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

BlackRock Fund Advisors's AERI Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Aerie Pharmaceuticals (AERI) stake by 57% in Q4 2016, buying an estimated $22.3M and bringing the position to 1,631,500 shares worth $61.8M. The position accounts for 0.01% of the portfolio, ranked #1547.

BlackRock Fund Advisors first reported a position in AERI in Q4 2013 and has held it in 13 quarters since. 151 funds tracked by Wall St. Rank hold AERI as of Q4 2016.

  • BlackRock Fund Advisors held 1,631,500 shares of Aerie Pharmaceuticals worth $61.8M as of Q4 2016.
  • BlackRock Fund Advisors bought 589,020 Aerie Pharmaceuticals shares in Q4 2016, an estimated $22.3M.
  • Aerie Pharmaceuticals made up 0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #1547 holding.
  • BlackRock Fund Advisors first reported a position in Aerie Pharmaceuticals in Q4 2013 and has held it in 13 quarters since.
  • 151 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.